| Drug Name |
Eptifibatide |
| Drug ID |
BADD_D00792 |
| Description |
Synthetic cyclic hexapeptide that binds to platelet receptor glycoprotein and inhibits platelet aggregation. Derived from venom of the Southeastern pygmy rattlesnake (Sistrurus miliarus barbouri), eptifibatide is a cyclic heptapeptide that belongs to the class of arginin-glycin-aspartat-mimetics. |
| Indications and Usage |
For treatment of myocardial infarction and acute coronary syndrome. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
B01AC16 |
| DrugBank ID |
DB00063
|
| KEGG ID |
D06888
|
| MeSH ID |
D000077542
|
| PubChem ID |
448812
|
| TTD Drug ID |
D09ZIO
|
| NDC Product Code |
67457-631; 32861-0002; 16729-260; 36974-0068; 72078-026; 70436-026; 14403-0007; 70121-1003; 52958-402; 55150-218; 55150-220; 70436-162; 68225-005; 70436-163; 52958-128; 0338-9559; 16729-259; 14335-070; 70121-1002; 14335-071; 17478-902; 55150-219; 41524-0002; 52958-001; 25021-409; 62756-500; 25021-408; 0338-9558; 68225-006; 70436-027; 72078-025; 67457-630; 17478-903; 70860-303; 72078-027; 67457-629 |
| Synonyms |
Eptifibatide | Epifibratide | Epifibatide | 7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)- | Integrilin | Integrelin |
